HDAC-1 mRNA was predominantly expressed in higher-stage (T3 or T4) lung cancer cases [55,58], and the strong HDAC-1 immunohistochemical expression (in terms of percentage and intensity) was associated with a remarkably poorer patient OS [55,58]. This evidence concerns the gene HDAC1 and lung cancer.